Pharmacological treatment of endometriosis: update from recent clinical trials

Simone Ferrero, Valentino Remorgida, Pier Luigi Venturini
In: Clinical Investigation · 2011 · vol. 1(1) , pp. 109–117 · doi:10.4155/cli.10.4 · W2053768378
article OA: closed CC0
View on OpenAlex View at publisher

Abstract

Endometriosis is a chronic disease that causes pain and infertility. Combined oral contraceptives and progestins are commonly used for the treatment of endometriosis because they reduce the severity of pain symptoms in 60–70% of patients and are well tolerated. Gonadotropin-releasing hormone analogs and danazol may be administered to selected patients but their long-term use is limited owing to the high frequency of severe adverse effects. Aromatase inhibitors should be administered only to women who fail to improve after surgery and conventional hormonal therapy because they are not well tolerated. This article discusses the medical therapies available for the treatment of endometriosis-related pain symptoms; in addition, detailed information on the recent advances in the treatment of rectovaginal endometriosis, ovarian endometriomas and bowel endometriosis is presented.

My notes (saved in your browser only)

Condition tags

endometriosisbowel_endometriosisinfertility

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (76)

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
unpaywall
last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0 · commercial use OK